Published in Am J Respir Crit Care Med on September 01, 2002
Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia. Ann Emerg Med (2008) 3.44
Disability among elderly survivors of mechanical ventilation. Am J Respir Crit Care Med (2010) 2.50
Validation of the Infectious Disease Society of America/American Thoracic Society 2007 guidelines for severe community-acquired pneumonia. Crit Care Med (2009) 2.32
Validation of predictive rules and indices of severity for community acquired pneumonia. Thorax (2004) 1.68
A prospective comparison of severity scores for identifying patients with severe community acquired pneumonia: reconsidering what is meant by severe pneumonia. Thorax (2006) 1.62
A simple score to predict the outcome of severe malaria in adults. Clin Infect Dis (2010) 1.54
Variants in the Mannose-binding Lectin Gene MBL2 do not Associate With Sepsis Susceptibility or Survival in a Large European Cohort. Clin Infect Dis (2015) 1.40
Late admission to the ICU in patients with community-acquired pneumonia is associated with higher mortality. Chest (2009) 1.40
Lower respiratory tract virus findings in mechanically ventilated patients with severe community-acquired pneumonia. Clin Infect Dis (2014) 1.36
Prospective comparison of three predictive rules for assessing severity of community-acquired pneumonia in Hong Kong. Thorax (2006) 1.35
Risk stratification of early admission to the intensive care unit of patients with no major criteria of severe community-acquired pneumonia: development of an international prediction rule. Crit Care (2009) 1.27
Demographics, guidelines, and clinical experience in severe community-acquired pneumonia. Crit Care (2008) 1.10
Multinational, observational study of procalcitonin in ICU patients with pneumonia requiring mechanical ventilation: a multicenter observational study. Crit Care (2011) 1.09
Long-term prognosis in community-acquired pneumonia. Curr Opin Infect Dis (2013) 1.06
Prediction of severe community-acquired pneumonia: a systematic review and meta-analysis. Crit Care (2012) 0.95
Patients with community acquired pneumonia admitted to European intensive care units: an epidemiological survey of the GenOSept cohort. Crit Care (2014) 0.94
ICU admission and severity assessment in community-acquired pneumonia. Crit Care (2009) 0.89
Shared and Distinct Aspects of the Sepsis Transcriptomic Response to Fecal Peritonitis and Pneumonia. Am J Respir Crit Care Med (2016) 0.87
Hypocapnia and hypercapnia are predictors for ICU admission and mortality in hospitalized patients with community-acquired pneumonia. Chest (2012) 0.84
Early cardiac arrest in patients hospitalized with pneumonia: a report from the American Heart Association's Get With The Guidelines-Resuscitation Program. Chest (2011) 0.83
Fluorocycline TP-271 Is Potent against Complicated Community-Acquired Bacterial Pneumonia Pathogens. mSphere (2017) 0.82
Defining and predicting severe community-acquired pneumonia. Curr Opin Infect Dis (2010) 0.78
Mortality of community-acquired pneumonia in Korea: assessed with the pneumonia severity index and the CURB-65 score. J Korean Med Sci (2013) 0.78
Improving the 2007 Infectious Disease Society of America/American Thoracic Society severe community-acquired pneumonia criteria to predict intensive care unit admission. J Crit Care (2012) 0.78
Blood culture fluorescence rates predict severity and mortality of invasive pneumococcal pneumonia. Eur J Clin Microbiol Infect Dis (2015) 0.77
Defining severe pneumonia. Clin Chest Med (2011) 0.77
Relationships among initial hospital triage, disease progression and mortality in community-acquired pneumonia. Respirology (2012) 0.77
Macrolide use in the treatment of critically ill patients with pneumonia: Incidence, correlates, timing and outcomes. Can J Infect Dis Med Microbiol (2013) 0.76
Time to intubation is associated with outcome in patients with community-acquired pneumonia. PLoS One (2013) 0.76
A Biomathematical Model of Pneumococcal Lung Infection and Antibiotic Treatment in Mice. PLoS One (2016) 0.75
Severe community-acquired pneumonia: timely management measures in the first 24 hours. Crit Care (2016) 0.75
Causes of non-adherence to therapeutic guidelines in severe community-acquired pneumonia. Rev Bras Ter Intensiva (2015) 0.75
PROGRESS - prospective observational study on hospitalized community acquired pneumonia. BMC Pulm Med (2016) 0.75
Severity assessment of lower respiratory tract infection in Malawi: derivation of a novel index (SWAT-Bp) which outperforms CRB-65. PLoS One (2013) 0.75
Score to identify the severity of adult patients with influenza A (H1N1) 2009 virus infection at hospital admission. Eur J Clin Microbiol Infect Dis (2012) 0.75
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med (2011) 28.99
Physician staffing patterns and clinical outcomes in critically ill patients: a systematic review. JAMA (2002) 9.89
RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care (2006) 9.29
Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N Engl J Med (2003) 6.70
Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial. Lancet (2011) 6.25
Veterans Affairs initiative to prevent methicillin-resistant Staphylococcus aureus infections. N Engl J Med (2011) 5.64
A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study. J Am Coll Cardiol (2011) 5.06
Critical care delivery in the United States: distribution of services and compliance with Leapfrog recommendations. Crit Care Med (2006) 4.85
The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. N Engl J Med (1990) 4.77
The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med (2002) 4.72
Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? JAMA (2003) 4.13
Telephone-delivered collaborative care for treating post-CABG depression: a randomized controlled trial. JAMA (2009) 4.06
Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis. Crit Care Med (2003) 4.04
Effect of age on stroke prevention therapy in patients with atrial fibrillation: the atrial fibrillation investigators. Stroke (2009) 3.89
Causes of death for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team cohort study. Arch Intern Med (2002) 3.78
Mortality among homeless adults in Boston: shifts in causes of death over a 15-year period. JAMA Intern Med (2013) 3.67
Long-term outcomes of surgical and nonsurgical management of lumbar spinal stenosis: 8 to 10 year results from the maine lumbar spine study. Spine (Phila Pa 1976) (2005) 3.67
The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch Intern Med (2004) 3.63
Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort study. BMJ (2006) 3.62
A controlled trial of web-based diabetes disease management: the MGH diabetes primary care improvement project. Diabetes Care (2003) 3.57
A comparison of three methods to estimate baseline creatinine for RIFLE classification. Nephrol Dial Transplant (2010) 3.45
Advancing health disparities research within the health care system: a conceptual framework. Am J Public Health (2006) 3.25
Long-term outcomes of surgical and nonsurgical management of sciatica secondary to a lumbar disc herniation: 10 year results from the maine lumbar spine study. Spine (Phila Pa 1976) (2005) 3.17
Effect of increasing the intensity of implementing pneumonia guidelines: a randomized, controlled trial. Ann Intern Med (2005) 3.13
Pneumonia: still the old man's friend? Arch Intern Med (2003) 3.12
Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis. Stroke (2003) 3.12
Tests of glycemia for the diagnosis of type 2 diabetes mellitus. Ann Intern Med (2002) 3.06
Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation. Ann Intern Med (2004) 3.06
Hospitalized community-acquired pneumonia in the elderly: age- and sex-related patterns of care and outcome in the United States. Am J Respir Crit Care Med (2002) 3.02
Conditional outlier detection for clinical alerting. AMIA Annu Symp Proc (2010) 2.99
Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis. JAMA (2002) 2.94
Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation. J Am Coll Cardiol (2008) 2.93
Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF. Lancet Neurol (2012) 2.77
Sensitivity and specificity of patient self-report of influenza and pneumococcal polysaccharide vaccinations among elderly outpatients in diverse patient care strata. Vaccine (2003) 2.76
Validation of a model to predict adverse outcomes in patients with pulmonary embolism. Eur Heart J (2005) 2.66
The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study. Circ Arrhythm Electrophysiol (2009) 2.59
SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia. Clin Infect Dis (2008) 2.56
Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med (2005) 2.51
Coxiella burnetii genotyping. Emerg Infect Dis (2005) 2.50
Prevalence, severity, and importance of physical and emotional symptoms in chronic hemodialysis patients. J Am Soc Nephrol (2005) 2.45
The unmet health care needs of homeless adults: a national study. Am J Public Health (2010) 2.36
Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment. Eur Heart J (2011) 2.31
Growth of intensive care unit resource use and its estimated cost in Medicare. Crit Care Med (2008) 2.31
Active care management supported by home telemonitoring in veterans with type 2 diabetes: the DiaTel randomized controlled trial. Diabetes Care (2009) 2.31
Observational study of inhaled corticosteroids on outcomes for COPD patients with pneumonia. Am J Respir Crit Care Med (2011) 2.30
Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population. Am J Cardiol (2013) 2.29
Association of cigarette smoking and media literacy about smoking among adolescents. J Adolesc Health (2006) 2.28
Swine outbreak of pandemic influenza A virus on a Canadian research farm supports human-to-swine transmission. Clin Infect Dis (2011) 2.28
Healthcare costs and long-term outcomes after acute respiratory distress syndrome: A phase III trial of inhaled nitric oxide. Crit Care Med (2006) 2.27
Testing strategies in the initial management of patients with community-acquired pneumonia. Ann Intern Med (2003) 2.27
Prognostic importance of hyponatremia in patients with acute pulmonary embolism. Am J Respir Crit Care Med (2010) 2.26
Viral infection in adults hospitalized with community-acquired pneumonia: prevalence, pathogens, and presentation. Chest (2008) 2.26
The relation between hyperglycemia and outcomes in 2,471 patients admitted to the hospital with community-acquired pneumonia. Diabetes Care (2005) 2.24
Perceptions of safety culture vary across the intensive care units of a single institution. Crit Care Med (2007) 2.24
A comprehensive career-success model for physician-scientists. Acad Med (2011) 2.20
Comparison of hyperglycemia, hypertension, and hypercholesterolemia management in patients with type 2 diabetes. Am J Med (2002) 2.19
Assessment of mortality after long-term follow-up of patients with community-acquired pneumonia. Clin Infect Dis (2003) 2.19
A prediction rule to identify low-risk patients with pulmonary embolism. Arch Intern Med (2006) 2.18
Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Circulation (2009) 2.18
Moving the tipping point: the decision to anticoagulate patients with atrial fibrillation. Circ Cardiovasc Qual Outcomes (2010) 2.17
Understanding racial disparities in HIV using data from the veterans aging cohort 3-site study and VA administrative data. Am J Public Health (2003) 2.16
Death and disability from warfarin-associated intracranial and extracranial hemorrhages. Am J Med (2007) 2.16
Investigations of the effects of gender, diurnal variation, and age in human urinary metabolomic profiles. Anal Chem (2007) 2.15
What affects influenza vaccination rates among older patients? An analysis from inner-city, suburban, rural, and Veterans Affairs practices. Am J Med (2003) 2.12
Haloperidol use is associated with lower hospital mortality in mechanically ventilated patients. Crit Care Med (2005) 2.11
Outlier detection for patient monitoring and alerting. J Biomed Inform (2012) 2.10
A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med (2007) 2.08
Diagnosis and management of Q fever--United States, 2013: recommendations from CDC and the Q Fever Working Group. MMWR Recomm Rep (2013) 2.06
Trends in complexity of diabetes care in the United States from 1991 to 2000. Arch Intern Med (2004) 2.06
Waterpipe smoking among U.S. university students. Nicotine Tob Res (2012) 2.02
Polypharmacy and medication adherence in patients with type 2 diabetes. Diabetes Care (2003) 2.00
Incidence and outcomes of contrast-induced AKI following computed tomography. Clin J Am Soc Nephrol (2008) 1.97
Burden of community-acquired pneumonia in North American adults. Postgrad Med (2010) 1.96
National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation. Arch Intern Med (2004) 1.92
Cost-effectiveness of inhaled nitric oxide in the treatment of neonatal respiratory failure in the United States. Pediatrics (2003) 1.92
Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine. Am J Med (2004) 1.87
Acute removal of common sepsis mediators does not explain the effects of extracorporeal blood purification in experimental sepsis. Kidney Int (2011) 1.87
A controlled trial of population management: diabetes mellitus: putting evidence into practice (DM-PEP). Diabetes Care (2004) 1.85
Mortality reduction with influenza vaccine in patients with pneumonia outside "flu" season: pleiotropic benefits or residual confounding? Am J Respir Crit Care Med (2008) 1.85
The acute inflammatory response in diverse shock states. Shock (2005) 1.83
Pulmonary embolism incidence is increasing with use of spiral computed tomography. Am J Med (2008) 1.82
Incidence of newly detected atrial arrhythmias via implantable devices in patients with a history of thromboembolic events. Stroke (2009) 1.81
Pneumococcal pneumonia: potential for diagnosis through a urinary metabolic profile. J Proteome Res (2009) 1.78
Routine use of the Pneumonia Severity Index for guiding the site-of-treatment decision of patients with pneumonia in the emergency department: a multicenter, prospective, observational, controlled cohort study. Clin Infect Dis (2006) 1.76
Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia. Am J Med (2005) 1.76